A Global Study Led by CU Medicine and University of Hong KongMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19
May 11, 2021
May 11, 2021
POKFULAM, Hong Kong, May 11 (TNSJou) -- The University of Hong Kong issued the following news release:
A recent global study led by researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) and the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) has discovered a hepatitis C virus drug "simeprevir" as a potent treatment for COVID-19, which can strongly suppress the replication of SARS-CoV-2. The combination of this drug wi . . .
A recent global study led by researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) and the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) has discovered a hepatitis C virus drug "simeprevir" as a potent treatment for COVID-19, which can strongly suppress the replication of SARS-CoV-2. The combination of this drug wi . . .